Visual capability map for the end-to-end Drug Research & Discovery operating model in this solution. Business and scientific purpose: this view supports faster, evidence-based drug discovery decisions across research, operations, and governance teams. Business Capability Model is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.
Program prioritization, milestone forecasts, and risk balancing.
Go/No-Go boards, evidence packs, and approval traceability.
Cross-program KPIs, bottleneck analysis, and throughput metrics.
Study design, protocol execution, and owner-level accountability.
Structured notebooking, witness/sign-off, and immutable evidence.
Assay definitions, run orchestration, QC review, and CAPA actions.
Sample custody, lot expiry tracking, and readiness controls.
Calibration windows, maintenance timeline, and utilization signals.
BigQuery-style assets, SQL exploration, preview, and results.
Provenance edges, FAIR checks, policy warnings, and schema quality.
Literature, patents, and source connectors for competitive awareness.
Target-pathway evidence graphs driving translational hypotheses.
Reproducible pipeline runs, queue control, logs, and artifacts.
Domain-specific agents with parameterized execution and outputs.
Task controls, consent/privacy, and full audit event history.
Validated export manifests and submission-ready bundles.
